Asston Pharmaceuticals Limited

₹146.15As of Sun 8 Nov 2026, 12:00 UTC
BSE:544445Healthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE 15.49%
Pharmaceutical Preparations
Beta (5Y) —
PE TTM 29.73
TSR TTM 75.87%
Mkt cap ₹1.596B
ROIC (1.65%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹152
3.88%
131.87%
Hold 1|11|4|7|5
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
2.16
2.28
2.24
2.43
(2.35%)
(5.22%)
(3.16%)
9.50%
Revenue₹M
145.4
143.9
141.5
146.5
3.32%
(1.57%)
(0.69%)
2.90%
Peers (US$16.41M)
Cap (US$)
PE
18.82M
5.918x
Capital
TTM
5Y
10Y
Leveragex
1.082
(0.957)
(0.724)
EBIT/Intx
2.518
0.303
0.323
Own earn%
124.11
66.94
67.74
Sh yield%
23.64
59.50
54.76
Owners
Insiders/Inst%
5.70
26.46
Short interest%
1.58
SBC / revenue%
3.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
4–12
$1 testx
0.0
Incr. ROIC%
0